BLBD SVP Scartz exercises options at $12.35 and sells shares at $55.22
Rhea-AI Filing Summary
Ted Scartz, SVP General Counsel of Blue Bird Corporation (BLBD), exercised vested stock options and completed a sale on 08/12/2025. The filing shows exercises of two vested tranches that produced 5,918 and 2,959 shares at an exercise price of $12.35 per share. The report also shows a sale of 8,877 shares at $55.22 per share. Following these transactions the reporting person’s beneficial ownership is reported as 48,769 common shares. The option award consisted of three equal annual tranches and this filing documents the exercise of the first two tranches, which vested on December 12, 2023 and December 12, 2024.
Positive
- Exercise of options generated 8,877 underlying shares via two vested tranches at an exercise price of $12.35
- Full disclosure of transactions including exercise and sale prices and post-transaction beneficial ownership (48,769 shares)
Negative
- Sale of 8,877 shares at $55.22 reduced the reporting person’s beneficial ownership to 48,769 shares
- No disclosure of use of sale proceeds or any plans for further transactions in the filing
Insights
TL;DR: Insider exercised two vested option tranches and sold shares; net beneficial ownership decreased to 48,769 shares.
The Form 4 documents option exercises at an exercise price of $12.35 for 5,918 and 2,959 shares respectively, and a contemporaneous sale of 8,877 shares at $55.22. These transactions reflect routine option vesting and monetization by an officer rather than an extraordinary corporate event. The filing does not disclose proceeds retained or use of proceeds, nor any change to control or 10% ownership status. Impact on ownership is explicit: beneficial holdings are reported as 48,769 shares after the activity.
TL;DR: Documented exercise of two vested option tranches and a sale; disclosures align with Rule 16 reporting for an officer.
The filing identifies Ted Scartz as an officer (SVP General Counsel) and reports the exercise of option tranches that vested on December 12, 2023 and December 12, 2024. The explanatory note states the award vests in three equal installments and confirms this filing covers the first two tranches. The Form 4 shows the required detail: transaction codes, share counts, exercise and sale prices, and post-transaction beneficial ownership. There are no additional governance actions or amendments disclosed.